CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Adaptimmune Therapeutics Plc  (ADAP)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Adaptimmune Therapeutics Plc's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

ADAP Gross Margin (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Sep 30 2016)
III. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
Y / Y Revenue Change -2.09 % - - - -
Y / Y Gross Profit Change - - - - -
Gross Margin - - - - -
Gross Margin Total Ranking # 51 # 829 # 613 # 80 # 663
Seq. Revenue Change -66.53 % 253.31 % 636.59 % -88.76 % -
Seq. Gross Profit Change - - - - -


Commenting First Quarter 2017 Gross Margin
Adaptimmune Therapeutics Plc experienced contraction in Gross Profit by -66.53 % to $3 millions and Revenue by -66.53 %, while Gross Margin fell to 100 % a new company low.

Observing first quarter 2017 results within Biotechnology & Drugs industry 6 other companies have achieved higher Gross Margin. While Gross Margin total ranking has impoved so far to 51, from total ranking in previous quarter at 829.
Learn about Gross Margin
ADAP's Gross Margin first quarter 2017 Company Ranking
Within: No.
Industry # 7
Sector # 17
S&P 500 # 51

Gross Margin Statistics
High Average Low
100 % 100 % 100 %
(Mar 31 2017)  

You need to upgrade your Flash Player


Financial Statements
Adaptimmune Therapeutics Plc's (Mar 31 2017) Gross Profit $ 3 ADAP's Income Statement
Adaptimmune Therapeutics Plc's (Mar 31 2016) Gross Profit $ 3 Quarterly ADAP's Growth
ADAP's Profits by Division See ADAP's Profits by Segment

Other Gross Margin Profitability Ratios
ADAP's Cumulative Gross Margin
Biotechnology & Drugs Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
ADAP's Gross Margin Profitability versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for ADAP's Competitors
Gross Margin Profit Margin for Adaptimmune Therapeutics Plc's Suppliers
Gross Margin Profit Margin for ADAP's Customers

You may also want to know
ADAP's Annual Growth Rates ADAP's Profitability Ratios ADAP's Asset Turnover Ratio ADAP's Dividend Growth
ADAP's Roe ADAP's Valuation Ratios ADAP's Financial Strength Ratios ADAP's Gross Profit Growth
ADAP's Roa ADAP's Inventory Turnover Ratio ADAP's Growth Rates ADAP's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Mar 31 2017, within Biotechnology & Drugs Industry Gross MarginMar 31 2017 MRQ Gross ProfitMar 31 2017 MRQ Revenue
Sangui Biotech International Inc  217.68 %$ 0.025 $ 0.012 
Innovus Pharmaceuticals, Inc.  100.00 %$ 2.177 $ 2.177 
Idera Pharmaceuticals, Inc.  100.00 %$ 0.378 $ 0.378 
Fate Therapeutics Inc  100.00 %$ 1.027 $ 1.027 
Juno Therapeutics, Inc.  100.00 %$ 19.327 $ 19.327 
Enzon Pharmaceuticals, Inc.  100.00 %$ 1.440 $ 1.440 
Momenta Pharmaceuticals Inc  100.00 %$ 26.614 $ 26.614 
Kite Pharma, Inc.  100.00 %$ 9.836 $ 9.836 
Mymetics Corp  100.00 %$ 0.383 $ 0.383 
Dimension Therapeutics, Inc.  100.00 %$ 3.618 $ 3.618 
Cocrystal Pharma, Inc.  100.00 %$ 0.002 $ 0.002 
Cannabics Pharmaceuticals Inc.  100.00 %$ 0.001 $ 0.001 
Curis Inc  100.00 %$ 2.131 $ 2.131 
Crispr Therapeutics Ag  100.00 %$ 2.703 $ 2.703 
Neuralstem, Inc.  100.00 %$ 0.003 $ 0.003 
Cytomx Therapeutics, Inc.  100.00 %$ 11.653 $ 11.653 
Myokardia Inc  100.00 %$ 5.625 $ 5.625 
Nantkwest, Inc.  100.00 %$ 0.011 $ 0.011 
Regenerx Biopharmaceuticals Inc  100.00 %$ 0.013 $ 0.013 
Proteostasis Therapeutics, Inc.  100.00 %$ 1.021 $ 1.021 
Proteo Inc  100.00 %$ 0.038 $ 0.038 
Repros Therapeutics Inc.  100.00 %$ 0.007 $ 0.007 
Sangamo Therapeutics, Inc  100.00 %$ 3.425 $ 3.425 
Tracon Pharmaceuticals, Inc.  100.00 %$ 0.626 $ 0.626 
Syndax Pharmaceuticals Inc  100.00 %$ 0.305 $ 0.305 
Tg Therapeutics, Inc.  100.00 %$ 0.038 $ 0.038 
Pulse Biosciences, Inc.  100.00 %$ 0.039 $ 0.039 
Intellia Therapeutics, Inc.  100.00 %$ 6.215 $ 6.215 
Coherus Biosciences, Inc.  100.00 %$ 0.161 $ 0.161 
Novavax Inc  100.00 %$ 5.680 $ 5.680 


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com